NanoSphere Health Sciences, LLC, innovative developers of the industry-first, patent-pending NanoSphere™ delivery system, announced that the U.S. Patent and Trademark office issued “Patent Pending” status for its new cannabis NanoSphere technology platform.

NanoSphere Health Sciences is the first and only patent-pending nanoparticle delivery system for medical and recreational cannabis. Concentrated “NanoSpheres” deliver plant extracts of cannabis and purified cannabinoids in convenient, standardized dosages to increase bioavailability, bioactivity and therapeutic potential. At the same time, the natural phospholipid particles decrease the adverse effects of cannabis.

“While significant advancements and investments have been made in the medical cannabis industry, we are the first to apply nanotechnology to improve the bioavailability and efficacy of cannabis extracts and standardized dosages,” said Dr. Richard Kaufman, Chief Science Officer at NanoSphere Health Sciences. “This disruptive technology introduces a significant advancement in the medical and recreational cannabis markets, and meets the regulatory demands for product purity, uniformity...